arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

DarioHealth Corp.

DRIO
$7.30 ▼ -0.49 (-6.29%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
61 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

DarioHealth Corp. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $48.1M
Dividend Yield
Revenue Growth -17.3%
Op. Margin -130.9%
ROIC -7.9%
FCF / Share $-0.92
Trailing P/E 5.8x
Price / Book 0.9x
FCF Yield
Debt / Equity 0.50
info Valuation on last close. End-of-day price, Aug 7, 2026.

61-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.58M
↓ -17.3%
Net Income Profit after all expenses
$-8.25M
↑ +10.6%
Operating Margin Operating profit as % of sales
-130.9%
↑ +30.9% 1th
FCF / Share Free cash flow per share
$-0.92
↑ +67.5%
Long-Term Debt Long-term obligations
$30.93M
↑ +0.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
14
Financial Health
42
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 61 quarters